Seeing Is Believing
Healthcare - Sector
ALT is currently covered by 2 analysts with an average price target of $18. This is a potential upside of $20.15 (478.78%) from yesterday's end of day stock price of $3.11.
Altimmune's activity chart (see below) currently has 82 price targets and 83 ratings on display. The stock rating distribution of ALT is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 14.55% with an average time for these price targets to be met of 52 days.
Highest price target for ALT is $25, Lowest price target is $11, average price target is $18.
Most recent stock forecast was given by from JMP on 14-May-2026. First documented stock forecast 27-Nov-2017.
Currently out of the existing stock ratings of ALT, 5 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Jul-2020
$11
$8.18 (290.07%)
$14
Buy Since 02-Jun-2021
$25
$22.18 (786.52%)
$12
Buy Since 12-Nov-2024
$24
$21.18 (751.06%)
$26
Buy Since 25-Sep-2020
$18
$15.18 (538.30%)
$20
Buy Since 01-Jun-2020
$25
$22.18 (786.52%)
$25
What is ALT (Altimmune) average time for price targets to be met?
Which analyst has the current highest performing score on ALT (Altimmune) with a proven track record?
Which analyst has the most public recommendations on ALT (Altimmune)?
Which analyst is the currently most bullish on ALT (Altimmune)?
Which analyst is the currently most reserved on ALT (Altimmune)?